金龍羽(002882.SZ):上半年淨利潤6671.6萬元 同比減少20.19%
格隆匯8月8日丨金龍羽(002882.SZ)公佈半年度報告,報告期內,公司營業收入215,652.66萬元,較上年同期增長32.98%,主要系公司積極拓展央企及國企類大客戶,同時加大省外市場及海外市場的推廣力度。實現歸屬於母公司股東的淨利潤6,671.60萬元,較上年同期減少20.19%,其中歸屬於母公司股東的扣非後淨利潤6,238.05萬元,較上年同期減少23.03%。公司營業收入增長但淨利潤下降的主要原因系市場競爭加劇,導致盈利水平下降,同時固態電池項目研發投入增加,綜合影響淨利潤。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.